Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy
使用 AMPK 激动剂 AICAR 进行长期治疗可预防骨骼肌病变,但无法改善重度脊髓性肌萎缩症小鼠模型的临床结果
期刊:Neurotherapeutics
影响因子:5.6
doi:10.1007/s13311-015-0399-x
Clàudia Cerveró, Neus Montull, Olga Tarabal, Lídia Piedrafita, Josep E Esquerda, Jordi Calderó